Cargando…

A computational modeling approach for dosing endoscopic intratumoral chemotherapy for advanced non-small cell lung cancer

We recently developed a computational model of cisplatin pharmacodynamics in an endobronchial lung tumor following ultrasound-guided transbronchial needle injection (EBUS-TBNI). The model suggests that it is more efficacious to apportion the cisplatin dose between injections at different sites rathe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mori, Vitor, Bates, Jason H. T., Jantz, Michael, Mehta, Hiren J., Kinsey, C. Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741990/ https://www.ncbi.nlm.nih.gov/pubmed/34996946 http://dx.doi.org/10.1038/s41598-021-03849-w

Ejemplares similares

Visualizing intratumoral injections in lung tumors by endobronchial ultrasound
por: Mori, Vitor, et al.
Publicado: (2023)

Tumor density is associated with response to endobronchial ultrasound-guided transbronchial needle injection of cisplatin
por: Kinsey, C. Matthew, et al.
Publicado: (2020)

Cisplatin Pharmacodynamics Following Endobronchial Ultrasound-Guided Transbronchial Needle Injection into Lung Tumors
por: Mori, Vitor, et al.
Publicado: (2019)

Management of chronic empyema with unexpandable lung in poor surgical risk patients using an empyema tube
por: Biswas, Abhishek, et al.
Publicado: (2016)

Predicting chemotherapy response in non-small-cell lung cancer via computed tomography radiomic features: Peritumoral, intratumoral, or combined?
por: Chang, Runsheng, et al.
Publicado: (2022)

Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer
por: Huang, Guanghui, et al.
Publicado: (2022)

Discriminating TB lung nodules from early lung cancers using deep learning
por: Tan, Heng, et al.
Publicado: (2022)

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2013)

A comparative study of intratumoral chemotherapy in advanced childhood common solid tumors
por: Rahi, Rajeev, et al.
Publicado: (2007)

Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2021)

Concomitant tracheal and subcutaneous glomus tumor: Case report and review of the literature
por: Fernandez-Bussy, Sebastian, et al.
Publicado: (2015)

Response to “Hypofractionated chemoradiotherapy for locally advanced non-small cell lung cancer: Is split-dose chemotherapy safer than full dose chemotherapy?”
por: Kepka, Lucyna, et al.
Publicado: (2021)

Therapeutic Endoscopic Ultrasonography: Intratumoral Injection for Pancreatic Adenocarcinoma
por: Shirley, Lawrence A., et al.
Publicado: (2013)

Minimally Invasive Methods for Staging in Lung Cancer: Systematic Review and Meta-Analysis
por: Labarca, Gonzalo, et al.
Publicado: (2016)

Repositioning of migrated self-expanding metallic tracheobronchial stent: predictors of a successful maneuver and its impact on survival
por: Biswas, Abhishek, et al.
Publicado: (2020)

Intratumoral Heterogeneity in Lung Cancer
por: Lv, Xiaodi, et al.
Publicado: (2023)

Clinico-immunological response to intratumoral versus intravenous neoadjuvant chemotherapy in advanced pediatric solid malignancies
por: Kumar, Vijayendra, et al.
Publicado: (2013)

Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
por: Yoo, Shin Hye, et al.
Publicado: (2021)

Detection and Clinical Significance of Intratumoral EGFR Mutational Heterogeneity in Chinese Patients with Advanced Non-Small Cell Lung Cancer
por: Bai, Hua, et al.
Publicado: (2013)

Feasibility of Intratumoral Confocal Microscopy under Endoscopic Ultrasound Guidance
por: Giovannini, Marc, et al.
Publicado: (2012)

Intratumoral heterogeneity generated by Notch signaling promotes small cell lung cancer
por: Lim, Jing Shan, et al.
Publicado: (2017)

Multivalent state transitions shape the intratumoral composition of small cell lung carcinoma
por: Gopal, Priyanka, et al.
Publicado: (2022)

Durvalumab after concurrent chemotherapy and high-dose radiotherapy for locally advanced non-small cell lung cancer
por: Landman, Yosef, et al.
Publicado: (2021)

Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
por: Martinez-Marti, A, et al.
Publicado: (2017)

Intratumor Heterogeneity in Early Lung Adenocarcinoma
por: Senosain, Maria-Fernanda, et al.
Publicado: (2020)

Can Hyperperfusion of Nonaerated Lung Explain COVID-19 Hypoxia?
por: Herrmann, Jacob, et al.
Publicado: (2020)

Radiofrequency heat-enhanced direct intratumoral chemotherapy for prostate cancer
por: Wu, Xia, et al.
Publicado: (2017)

Intratumoral radiofrequency hyperthermia-enhanced direct chemotherapy of pancreatic cancer
por: Bai, Zhibin, et al.
Publicado: (2016)

Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
por: Wu, Chunsheng, et al.
Publicado: (2020)

Intratumoral anti-HuD immunotoxin therapy for small cell lung cancer and neuroblastoma
por: Ehrlich, Debra, et al.
Publicado: (2014)

Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia
por: Herrmann, Jacob, et al.
Publicado: (2020)

Chemotherapy in non-small cell lung cancer: opportunities for advancement
por: Akhtari, Mani, et al.
Publicado: (2016)

Quantitative Computed Tomographic Descriptors Associate Tumor Shape Complexity and Intratumor Heterogeneity with Prognosis in Lung Adenocarcinoma
por: Grove, Olya, et al.
Publicado: (2015)

Symptom relief with moderate dose chemotherapy (mitomycin-C, vinblastine and cisplatin) in advanced non-small cell lung cancer.
por: Hardy, J. R., et al.
Publicado: (1989)

Relative dose intensity of first-line chemotherapy and overall survival in patients with advanced non-small-cell lung cancer
por: Crawford, Jeffrey, et al.
Publicado: (2019)

Enhancement of Intratumoral Chemotherapy with Cisplatin with or without Microwave Ablation and Lipiodol. Future Concept for Local Treatment in Lung Cancer
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2015)

Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer
por: Zhou, Juan, et al.
Publicado: (2022)

Modeling Lung Derecruitment in VILI Due to Fluid-Occlusion: The Role of Emergent Behavior
por: Mori, Vitor, et al.
Publicado: (2020)

Multiple layers of intratumor heterogeneity: clues to clonal evolution of non-small cell lung cancer
por: Dietz, Steffen, et al.
Publicado: (2019)

Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer
por: Jia, Qingzhu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2ago7737b2g7arjrh1g7ikpncf